@article{6123ba7467854f33ac3ba163653ea8b9,
title = "Evaluating Immune Checkpoint Inhibition in Solid Tumor patients with Homologous Recombination Repair Deficiency",
author = "Santiago Aparo and Madueno, \{Fernando Manuel Vargas\} and Wenrui Duan and Zuanel Diaz and Diaz, \{John Paul\} and Federico Albrecht and Siddharta Venkatappa and Schroeder, \{Eric Douglas\} and Vanessa Yanek and Gail Walker and Miguel Villalona",
note = "TPS3108 Background: Recent studies have shown that patients with mismatch repair deficiency have an increased response rate to immune checkpoint inhibitors (ICI). This led to the tissue-agnostic FDA approval of pembrolizumab (PEM).",
year = "2018",
language = "American English",
volume = "36",
journal = "Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting",
}